131 related articles for article (PubMed ID: 15507514)
1. Activation of caspases-3, -6, and -9 during finasteride treatment of benign prostatic hyperplasia.
Bozec A; Ruffion A; Decaussin M; Andre J; Devonec M; Benahmed M; Mauduit C
J Clin Endocrinol Metab; 2005 Jan; 90(1):17-25. PubMed ID: 15507514
[TBL] [Abstract][Full Text] [Related]
2. Expression of basic fibroblast growth factor and its receptors FGFR1 and FGFR2 in human benign prostatic hyperplasia treated with finasteride.
Sáez C; González-Baena AC; Japón MA; Giráldez J; Segura DI; Rodríguez-Vallejo JM; González-Esteban J; Miranda G; Torrubia F
Prostate; 1999 Jul; 40(2):83-8. PubMed ID: 10386468
[TBL] [Abstract][Full Text] [Related]
3. Finasteride targets prostate vascularity by inducing apoptosis and inhibiting cell adhesion of benign and malignant prostate cells.
Sutton MT; Yingling M; Vyas A; Atiemo H; Borkowski A; Jacobs SC; Kyprianou N
Prostate; 2006 Aug; 66(11):1194-202. PubMed ID: 16652387
[TBL] [Abstract][Full Text] [Related]
4. Long-term apoptotic cell death process with increased expression and activation of caspase-3 and -6 in adult rat germ cells exposed in utero to flutamide.
Omezzine A; Chater S; Mauduit C; Florin A; Tabone E; Chuzel F; Bars R; Benahmed M
Endocrinology; 2003 Feb; 144(2):648-61. PubMed ID: 12538628
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate.
Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS
J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433
[TBL] [Abstract][Full Text] [Related]
6. Induction of apoptosis in BPH stromal cells by adenoviral-mediated overexpression of caspase-7.
Marcelli M; Shao TC; Li X; Yin H; Marani M; Denner L; Teng B; Cunningham GR
J Urol; 2000 Aug; 164(2):518-25. PubMed ID: 10893637
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.
Glassman DT; Chon JK; Borkowski A; Jacobs SC; Kyprianou N
Prostate; 2001 Jan; 46(1):45-51. PubMed ID: 11170131
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin-induced apoptosis in prostate stromal cells.
Padayatty SJ; Marcelli M; Shao TC; Cunningham GR
J Clin Endocrinol Metab; 1997 May; 82(5):1434-9. PubMed ID: 9141529
[TBL] [Abstract][Full Text] [Related]
9. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
10. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of androgen induces autophagy in benign prostate epithelial cells.
Li M; Yang X; Wang H; Xu E; Xi Z
Int J Urol; 2014 Feb; 21(2):195-9. PubMed ID: 23819759
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
[TBL] [Abstract][Full Text] [Related]
13. 5alpha-reductase inhibitors/finasteride.
Stoner E
Prostate Suppl; 1996; 6():82-7. PubMed ID: 8630236
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic and proliferative index after Alpha-1-adrenoceptor antagonist and/or finasteride treatment in benign prostatic hyperplasia.
Erdoğru T; Ciftcioglu MA; Emreoglu I; Usta MF; Koksal T; Ozbilim G; Gulkesen KH; Baykara M
Urol Int; 2002; 69(4):287-92. PubMed ID: 12444285
[TBL] [Abstract][Full Text] [Related]
15. The effect of finasteride on prostate specific antigen: review of available data.
Guess HA; Gormley GJ; Stoner E; Oesterling JE
J Urol; 1996 Jan; 155(1):3-9. PubMed ID: 7490873
[TBL] [Abstract][Full Text] [Related]
16. Chinese Skullcap (Scutellaria baicalensis Georgi) inhibits inflammation and proliferation on benign prostatic hyperplasia in rats.
Jin BR; Chung KS; Kim HJ; An HJ
J Ethnopharmacol; 2019 May; 235():481-488. PubMed ID: 30708034
[TBL] [Abstract][Full Text] [Related]
17. Finasteride in the treatment of benign prostatic hyperplasia.
Ekman P; Andersen JT; Wolf H
Acta Urol Belg; 1996 Mar; 64(1):IX-XII. PubMed ID: 8659328
[TBL] [Abstract][Full Text] [Related]
18. Finasteride-induced prostatic involution by apoptosis in dogs with benign prostatic hypertrophy.
Sirinarumitr K; Sirinarumitr T; Johnston SD; Sarkar DK; Kustritz MV
Am J Vet Res; 2002 Apr; 63(4):495-8. PubMed ID: 11939309
[TBL] [Abstract][Full Text] [Related]
19. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
Marcelli M; Cunningham GR; Haidacher SJ; Padayatty SJ; Sturgis L; Kagan C; Denner L
Cancer Res; 1998 Jan; 58(1):76-83. PubMed ID: 9426061
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of finasteride therapy for benign prostatic hyperplasia: results of a 2-year randomized controlled trial (the PROSPECT study). PROscar Safety Plus Efficacy Canadian Two year Study.
Nickel JC; Fradet Y; Boake RC; Pommerville PJ; Perreault JP; Afridi SK; Elhilali MM
CMAJ; 1996 Nov; 155(9):1251-9. PubMed ID: 8911291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
